Published in Clin Exp Immunol on June 01, 1985
Activation of B chronic lymphocytic leukaemia cells by Branhamella catarrhalis. Immunology (1987) 0.79
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31
The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol (1976) 4.40
Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood (1972) 2.91
Immunoglobulins on the surface of neoplastic lymphocytes. N Engl J Med (1972) 2.63
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals. Lancet (1974) 2.18
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1974) 2.13
Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin Exp Immunol (1973) 2.11
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes. Int Arch Allergy Appl Immunol (1975) 1.89
T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol (1979) 1.74
Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med (1980) 1.57
Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells. Blood (1981) 1.25
T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribtuion and in in vitro receptor maturation. Blood (1979) 1.22
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
In vitro induction of IgM secretion and switching to IgG production in human B leukemic cells with the help of T cells. J Immunol (1980) 1.08
Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J Immunol (1982) 1.08
Receptors for IgA on a subpopulation of human B lymphocytes. Proc Natl Acad Sci U S A (1979) 1.08
Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia. Br J Haematol (1981) 1.01
Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. Scand J Haematol (1980) 0.99
Surface immunoglobulins of leukaemic cells. Clin Exp Immunol (1973) 0.98
Induction of monoclonal antibody synthesis in malignant human B cells by polyclonal B cell activators. Relationship between B cell subsets and prognosis. Immunol Rev (1979) 0.89
Receptors for IgM on human B lymphocytes. Scand J Immunol (1978) 0.89
Defective immunoregulatory T-cell function in chronic lymphocytic leukemia. Blood (1981) 0.86
Separation of human lymphocyte subpopulations by density gradient electrophoresis. I. Different mobilities of T (T mu, T alpha) and B lymphocytes from human tonsils. Cell Immunol (1980) 0.81
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1980) 0.80
Preparative electrophoresis of living mammalian cells in a stationary ficoll gradient. Prep Biochem (1973) 0.79
Electrophoretic separation of cells in a density gradient. Life Sci (1975) 0.79
Separation of T and B lymphocytes from various mouse strains by density gradient electrophoresis. Cell Biophys (1979) 0.77
Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen. Proc Natl Acad Sci U S A (1981) 4.38
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med (1988) 1.98
Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens. Proc Natl Acad Sci U S A (1981) 1.41
Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg (1990) 1.32
Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg (2001) 1.29
T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol (1998) 1.20
Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering. Eur J Immunol (1984) 1.16
Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells. J Immunol (1981) 1.12
Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Res (1991) 1.12
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods (1994) 1.11
Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol (1991) 1.09
Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J Immunol (1982) 1.08
Receptors for IgA on a subpopulation of human B lymphocytes. Proc Natl Acad Sci U S A (1979) 1.08
Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes. Cancer Treat Res (1996) 1.07
Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis. Clin Diagn Lab Immunol (1999) 1.05
HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol (1996) 1.04
Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res (1993) 0.98
Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibody. Proc Natl Acad Sci U S A (1987) 0.97
Receptors for IgA on a subpopulation of human T and B lymphocytes. Cell Immunol (1979) 0.95
Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120. Virology (1992) 0.94
HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer (1994) 0.94
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res (2000) 0.93
Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice. Virology (2000) 0.93
Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+. Proc Natl Acad Sci U S A (1989) 0.91
Preparation and characterization of monoclonal antibodies directed at epitopes of human IFN-gamma. Hybridoma (1984) 0.91
Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors. Eur J Immunol (1992) 0.91
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines. Clin Exp Immunol (1998) 0.90
Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma. Clin Cancer Res (1999) 0.89
Interleukin-12 is expressed by infiltrating macrophages and synovial lining cells in rheumatoid arthritis and osteoarthritis. Cell Immunol (1998) 0.89
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis. Clin Cancer Res (1998) 0.88
Separation of human T lymphocyte subpopulations (Tmu, Tgamma) by density gradient electrophoresis. Proc Natl Acad Sci U S A (1979) 0.87
Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res (1990) 0.86
Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin Diagn Lab Immunol (1999) 0.86
Purine nucleoside modulation of functions of human lymphocytes. Cell Immunol (1990) 0.85
Malignant melanoma: relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II. Cancer (1996) 0.85
Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells. Cell Immunol (1986) 0.85
Immunology of Theiler's murine encephalomyelitis virus infection. Immunol Res (1995) 0.84
Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs. Scand J Immunol (1992) 0.83
All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp Cell Res (1997) 0.83
T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies. J Clin Immunol (1983) 0.83
Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity. Cell Immunol (1987) 0.81
Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection. Clin Diagn Lab Immunol (2001) 0.81
Separation of human lymphocyte subpopulations by density gradient electrophoresis. I. Different mobilities of T (T mu, T alpha) and B lymphocytes from human tonsils. Cell Immunol (1980) 0.81
Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol (1994) 0.81
Lymphokine production by human melanoma tumor-infiltrating lymphocytes. Cancer Immunol Immunother (1992) 0.81
Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation. Cell Immunol (1988) 0.81
Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes. Cancer Res (1989) 0.80
Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines Cell Mol Ther (1998) 0.80
OKT4 monoclonal antibody-induced activation of an autoreactive T-cell clone. Cell Immunol (1989) 0.80
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1980) 0.80
Amplification of T-cell receptor alpha- and beta-chain transcripts from mouse spleen lymphocytes by the nonpalindromic adaptor-polymerase chain reaction. Hematopathol Mol Hematol (1998) 0.80
Apoptosis in chronic rejection of human cardiac allografts. Transplantation (2001) 0.80
Separation of human bone marrow cell populations by density gradient electrophoresis: differential mobilities of myeloid (CFU-C), monocytoid, and lymphoid cells. Cell Immunol (1981) 0.79
Separation of rat T and B lymphocytes by density gradient electrophoresis. J Immunol Methods (1979) 0.79
Novel immunologic strategies in ovarian carcinoma. Am J Obstet Gynecol (1992) 0.79
Development of a monoclonal antibody specific for the gamma chain of the T-cell antigen receptor using an open reading frame expression vector. Hybridoma (1989) 0.78
The delta TCS1 determinant is expressed on both disulfide- and non-disulfide-linked gamma delta T-cell antigen receptors. Blood (1991) 0.78
Partial separation of human blood leukocytes by density gradient electrophoresis:different mobilities of lymphocytes with IgG, those with IgM and IgD, T lymphocytes, and monocytes. J Immunol (1976) 0.78
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin Exp Immunol (2000) 0.78
Amplification of immunoglobulin transcripts by the non-palindromic adaptor polymerase chain reaction (NPA-PCR). Nucleotide sequence analysis of two human monoclonal antibodies recognizing two cell surface antigens expressed in ovarian, cervix, breast, colon and other carcinomas. Hum Antibodies Hybridomas (1994) 0.78
CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production. Cell Immunol (1988) 0.78
Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts. Clin Diagn Lab Immunol (1996) 0.78
T-cell functions in ovarian cancer patients treated with viral oncolysates: I. Increased helper activity to immunoglobulins production. Anticancer Res (1990) 0.77
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma. J Immunother Emphasis Tumor Immunol (1996) 0.77
Disulfide-linked gamma delta T cell antigen receptors expressed on T cells derived from patients with primary immunodeficiency disorders. J Clin Invest (1989) 0.77
Disulfide-linked and non-disulfide-linked gamma/delta T-cell antigen receptors: differential expression on T-cell lines and clones derived from normal donors and patients with primary immunodeficiency disorders. Anticancer Res (1992) 0.77
T-cell antigen receptors in rheumatoid arthritis. Immunol Res (1994) 0.77
Density gradient electrophoresis of mouse spleen lymphocytes: separation of T and B cell fractions. J Immunol Methods (1976) 0.77
Immunological effects of tumor vaccines: II. T cell responses directed against cellular antigens in the viral oncolysates. In Vivo (1991) 0.77
Preferential rearrangements of the V gamma I subgroup of the gamma-chain of the T-cell antigen receptor to J gamma 2C gamma 2 gene segments in peripheral blood lymphocyte transcripts from normal donors. Scand J Immunol (1993) 0.77
Separation of T and B lymphocytes from various mouse strains by density gradient electrophoresis. Cell Biophys (1979) 0.77
Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts. Clin Exp Immunol (2005) 0.77
Leukaemic B cells from patients with chronic lymphocytic leukaemia suppress immunoglobulin production by lymphocytes from normal donors. Scand J Immunol (1988) 0.77
Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study. Hum Gene Ther (1996) 0.76
Association of HLA-DOB1*0301 with malignant melanoma. J Immunother Emphasis Tumor Immunol (1996) 0.75
Coronary arteries with chronic rejection contain oligoclonal T cells: persistence of clonally expanded T cell receptor transcripts from the early posttransplantation period through chronic rejection. Transplant Proc (2001) 0.75
B cells from a patient with chronic lymphocytic leukemia bind to sheep erythrocytes: an immunological analysis. Clin Immunol Immunopathol (1980) 0.75
Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector. Hum Gene Ther (1995) 0.75
Immunoglobulin synthesis and secretion by leukemic B cells from patients with chronic lymphocytic leukemia. Leuk Res (1986) 0.75
Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC. Immunol Res (1995) 0.75
Human hybridoma-derived suppressor factor 160 and transforming growth factor-beta are different molecules. Lymphokine Cytokine Res (1992) 0.75
Gamma-chain T-cell receptor transcripts are clonally expanded in the coronary arteries of cardiac allografts from patients with chronic rejection. Transplant Proc (2001) 0.75
Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells. Cell Immunol (1987) 0.75
Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferons. Int Arch Allergy Appl Immunol (1988) 0.75
Density gradient electrophoresis of mouse spleen lymphocytes: age-related differences. A critical thymus-dependent event during development in the young adult mouse. J Immunol Methods (1980) 0.75
Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium. Scand J Immunol (1987) 0.75
Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers. Effect of monocytes. Int Arch Allergy Appl Immunol (1986) 0.75
Inhibition of interleukin 2 production and alteration of interleukin 2 mRNA processing by human T-T cell hybridoma-derived suppressor factors. Hybridoma (1994) 0.75
Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma. Scand J Immunol (1986) 0.75
T cells infiltrating coronary arteries of cardiac allografts with chronic rejection contain clonally expanded T lymphocytes. Transplant Proc (1998) 0.75
RT-PCR quantitation of cytokine responses in vivo from specimens containing small numbers of cells during bioimmunotherapy. J Immunol Methods (1998) 0.75
Density gradient electrophoresis of mouse spleen lymphocytes. Differential mobilities of macrophages, responding and stimulating cells in mixed lymphocyte culture. Int Arch Allergy Appl Immunol (1980) 0.75
Inhibition of spontaneous proliferation of human leukemic B cells from patients with chronic lymphocytic leukemia by anti-mu antibodies. Clin Immunol Immunopathol (1987) 0.75
Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells. Hum Antibodies Hybridomas (1991) 0.75
Human T-T cell hybridomas: development and applications. Hum Antibodies Hybridomas (1990) 0.75